RICHARD K. PRINS - 09 Dec 2024 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
09 Dec 2024
Net transactions value
-$242,502
Form type
4
Filing time
11 Dec 2024, 20:28:14 UTC
Previous filing
13 Nov 2024
Next filing
15 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $195,200 +10,000 +33% $19.52 40,471 09 Dec 2024 Direct
transaction AMPH Common Stock Sale $437,702 -10,000 -25% $43.77 30,471 09 Dec 2024 Direct F1
transaction AMPH Common Stock Gift $0 -410 -1.3% $0.000000 30,061 09 Dec 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Options Exercise $0 -10,000 -100% $0.000000 0 09 Dec 2024 Common Stock 10,000 $19.52 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.75 to $43.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F2 Shares subject to the option are fully vested and immediately exercisable.